Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interleukin-2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01697527
What this trial is testing

Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Malignant Neoplasm
Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT00582790
What this trial is testing

Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
University of Wisconsin, Madison 12
Testing effectiveness (Phase 2)WithdrawnNCT01324960
What this trial is testing

Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies
Not applicableStudy completedNCT00912418
What this trial is testing

Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 14
Testing effectiveness (Phase 2)UnknownNCT00003743
What this trial is testing

Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation

Who this might be right for
Neuroblastoma
St. Anna Kinderkrebsforschung 25
Testing effectiveness (Phase 2)Study completedNCT00056797
What this trial is testing

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Testing effectiveness (Phase 2)Study completedNCT00113282
What this trial is testing

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 57
Early research (Phase 1)Study completedNCT01144247
What this trial is testing

Cellular Immunotherapy Study for Brain Cancer

Who this might be right for
GliomasAnaplastic AstrocytomaAnaplastic Oligodendroglioma+3 more
Jonsson Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT05307874
What this trial is testing

Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
ImCheck Therapeutics, an Ipsen company 56
Early research (Phase 1)Study completedNCT01671774
What this trial is testing

Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Gastric AdenocarcinomaCLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of Esophagus
Astellas Pharma Global Development, Inc. 29
Testing effectiveness (Phase 2)Ended earlyNCT03308786
What this trial is testing

HIV Reservoir Reduction With Interleukin-2

Who this might be right for
HIV Infection
Case Western Reserve University 9
Early research (Phase 1)Study completedNCT00329368
What this trial is testing

Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer

Who this might be right for
Cancer
Endocyte 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT02306954
What this trial is testing

Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Providence Health & Services 84
Testing effectiveness (Phase 2)Study completedNCT02424396
What this trial is testing

Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 30
Early research (Phase 1)Study completedNCT00002321
What this trial is testing

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Chiron Corporation
Large-scale testing (Phase 3)Study completedNCT02278887
What this trial is testing

Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
The Netherlands Cancer Institute 168
Large-scale testing (Phase 3)UnknownNCT05631717
What this trial is testing

The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Testing effectiveness (Phase 2)Ended earlyNCT04009681
What this trial is testing

A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)

Who this might be right for
Metastasis
Synthorx, Inc, a Sanofi company 175
Testing effectiveness (Phase 2)Looking for participantsNCT07651319
What this trial is testing

Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

Who this might be right for
Alzheimer Dementia (AD)
The Methodist Hospital Research Institute 30
Early research (Phase 1)Study completedNCT01032681
What this trial is testing

EMD 521873 in Advanced Solid Tumors, MTD Finding

Who this might be right for
Non-Hodgkin Lymphoma
Merck KGaA, Darmstadt, Germany 66
Next Page